First Rituxan biosimilar Truxima set to make its debut in USBiosimilar competition to Roche’s big-selling Rituxan has arrived in the US, with Teva gearing up to launch its Share XFirst Rituxan biosimilar Truxima set to make its debut in UShttps://pharmaphorum.com/news/first-rituxan-biosimilar-truxima-set-to-makes-its-debut-in-us/
Secret US-UK talks on drug pricing revealedDespite the UK still not leaving the European Union – pencilled in for the 31 January 2020 at Share XSecret US-UK talks on drug pricing revealedhttps://pharmaphorum.com/views-analysis-market-access/secret-us-uk-talks-on-drug-pricing-revealed/
Measuring value to ensure access in divisive timesGlobally, balancing rising healthcare costs with the drive for innovation is a political hot potato – is a Share XMeasuring value to ensure access in divisive timeshttps://pharmaphorum.com/views-analysis-market-access/measuring-value-to-ensure-access-in-divisive-times/
California is first US state to ban pay-for-delay dealsCalifornia has become the first US state to ban the pharma industry practice of paying rivals to keep Share XCalifornia is first US state to ban pay-for-delay dealshttps://pharmaphorum.com/news/california-is-first-us-state-to-ban-pay-for-delay-deals/
Medicare coverage for CAR-T drugs on the horizonMedicare could soon cover CAR-T therapies under new proposals from the US’ Centers for Medicare & Medicaid Services Share XMedicare coverage for CAR-T drugs on the horizonhttps://pharmaphorum.com/news/medicare-coverage-for-car-t-drugs-on-the-horizon/
Democrats escalate US war on drug pricingIt was the newly-empowered Democrats’ turn to take on pharma drug pricing in the US this week, as Share XDemocrats escalate US war on drug pricinghttps://pharmaphorum.com/news/democrats-escalate-us-war-drug-pricing/
Trump’s war on drug pricing looks set to continueShrugging off warnings from president Donald Trump, pharma companies have announced US price hikes on more than 250 Share XTrump’s war on drug pricing looks set to continuehttps://pharmaphorum.com/market-access-2/trumps-war-on-drug-pricing-looks-set-to-continue/
Ashfield Healthcare Communications appoints new Global Commercial DirectorAshfield, part of UDG Healthcare, a leading global healthcare services provider, has appointed Ben Beckley as Global Commercial Share XAshfield Healthcare Communications appoints new Global Commercial Directorhttps://pharmaphorum.com/partner-content/ashfield-healthcare-communications-appoints-new-global-commercial-director/
How RACE legislation is changing the face of pediatric oncology in the USOn August 12 of this year the US senate unanimously passed the Race to Accelerate Cures and Equity Share XHow RACE legislation is changing the face of pediatric oncology in the UShttps://pharmaphorum.com/partner-content-oncology/race-legislation-changing-face-pediatric-oncology-us/
